Another part of the data (CGGA mRNA-array_301, GSE4271, GSE13041_GPL96, and TCGA_glioma dataset) suggested that SYDE1 expression was significantly lower in the neural or PN subtypes (p < 0.05, Figures 6A–C,E). The gene discussed is SYDE1; the disease is central nervous system cancer.